Nanotechnology Startups

HelixNano develops an mRNA platform aimed at applications including cancer treatment, COVID-19 vaccines, and environmental interventions. The company is working on a COVID-19 vaccine candidate for immunocompromised patients and other mRNA-based technologies.

16 investors

Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.

7 investors

Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.

7 investors

Arylla makes an invisible, chip-less printable tag that can be scanned with any smartphone through its API, connecting physical products to the internet. It prints tags onto products at scale using existing commercial printers and licenses its API to developers building services on top of the tag, positioning itself as a cheaper, more scalable alternative to NFC.

3 investors

Spotless Materials develops PFAS-free repellent coatings that reduce surface fouling and contamination on glass, metal, ceramic, and plastic surfaces. Initially launched as a consumer product, the coatings are now used in industrial applications including medical devices, diagnostic equipment, and automotive components.

3 investors

Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.

2 investors

Kern Systems develops DNA-based data storage, using enzymatic DNA synthesis and custom digital codecs to encode information. It aims to build scalable information infrastructure stored in DNA as an alternative to current memory technologies.

2 investors

Keylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.

2 investors

Shield Bio is a precision medicine company developing a platform for third-generation nanopore DNA sequencing that produces results in under a minute in clinical settings. It is initially applying the technology to infectious disease treatment and sepsis diagnostics.

1 investor

Silver develops a miniaturized Raman spectroscope paired with proprietary nanoparticle substrates that lets consumers instantly detect contaminants and toxins. It targets the consumer market with a low-cost handheld toxin-detection device.

1 investor